Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 2,083 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $21.00, for a total transaction of $43,743.00. Following the completion of the sale, the chief accounting officer owned 858 shares of the company’s stock, valued at approximately $18,018. This represents a 70.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Craig Gracey also recently made the following trade(s):

• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The stock was sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Performance

NASDAQ:OMDA traded up $0.28 during trading on Tuesday, reaching $21.95. The company’s stock had a trading volume of 853,685 shares, compared to its average volume of 1,070,637. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The firm has a market cap of $1.30 billion and a price-to-earnings ratio of -81.30. The firm has a 50 day moving average of $16.83 and a 200-day moving average of $14.93.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million for the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. Equities research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Trading of Omada Health

Several hedge funds and other institutional investors have recently modified their holdings of OMDA. Perceptive Advisors LLC purchased a new stake in shares of Omada Health during the 2nd quarter valued at approximately $44,402,000. Millennium Management LLC raised its holdings in Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after acquiring an additional 2,096,705 shares during the period. Divisadero Street Capital Management LP bought a new stake in Omada Health during the 3rd quarter valued at $30,510,000. Jefferies Financial Group Inc. purchased a new stake in shares of Omada Health during the fourth quarter worth $16,948,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Omada Health during the first quarter worth $10,401,000.

Analyst Ratings Changes

Several analysts have commented on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Citigroup reissued an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. Wells Fargo & Company raised their price target on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Finally, Barclays upped their price objective on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.